| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2002 | WO2002053101A2 Method for treating fibrotic diseases or other indications |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002053099A2 Methods and compositions for treating periodontal disease |
| 07/11/2002 | WO2002053097A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | WO2002053096A2 Single therapy and combination therapy involving drugs with target cellular proteins and drugs which target pathogen-encoded proteins |
| 07/11/2002 | WO2002053094A2 Method for detoxifying a carbohydrate containing solution |
| 07/11/2002 | WO2002053091A2 Medicinal combination of a biguanine (metformin) and arginine |
| 07/11/2002 | WO2002053090A2 Medicinal association of a biguanine (metformin) and arginine |
| 07/11/2002 | WO2002053089A2 Stable skin conditioning compositions containing retinoid boosters |
| 07/11/2002 | WO2002052957A1 Creatine/citric acid compound, method for the production of the same and the use thereof |
| 07/11/2002 | WO2002052955A1 Nutritional and therapeutical preparations having antioxidant activity |
| 07/11/2002 | WO2002052936A1 Preserving agents for freeze-dried cells |
| 07/11/2002 | WO2002041918A3 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage |
| 07/11/2002 | WO2002039984A3 Medicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 07/11/2002 | WO2002039980A3 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole |
| 07/11/2002 | WO2002038156A3 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria |
| 07/11/2002 | WO2002038144A8 The use of tiagabine for treatment of diabetic neuropathy and migraine |
| 07/11/2002 | WO2002036734A3 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 07/11/2002 | WO2002036605A3 Estrone-derivatives having cytoprotective activity |
| 07/11/2002 | WO2002034754A3 Benzoxazinone derivatives, their preparation and use |
| 07/11/2002 | WO2002034705A3 C-nitroso compounds and use thereof |
| 07/11/2002 | WO2002034119A3 Vaccine immunotherapy for immune suppressed patients |
| 07/11/2002 | WO2002030889A3 A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 07/11/2002 | WO2002030411A8 Treatment of apoptotic cell death |
| 07/11/2002 | WO2002030410A3 Suppression of cyclin kinase activity for prevention and treatment of infections |
| 07/11/2002 | WO2002030354A3 Uridine therapy for patients with elevated purine levels |
| 07/11/2002 | WO2002028880A8 Compounds useful for treating hypertriglyceridemia |
| 07/11/2002 | WO2002028349A3 Method of treating cancer using dithiocarbamate derivatives |
| 07/11/2002 | WO2002026716A3 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002020022B1 Method of treating neurologic disorders |
| 07/11/2002 | WO2002019969A3 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 07/11/2002 | WO2002019965A3 Heat shock response and virus replication |
| 07/11/2002 | WO2002019962A3 Therapeutic and cosmetic uses of heparanases |
| 07/11/2002 | WO2002018348A3 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002011716A3 Liquid formulation of metformin |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2002003987A3 Pharmaceutical compositions of estrogenic agents |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | WO2001095890B1 Oral pharmaceutical compositions containing terbinafine |
| 07/11/2002 | WO2001094550A3 Identification and use of molecular markers indicating cellular reprogramming |
| 07/11/2002 | WO2001091783A3 Methods and compositions for producing a neurosalutary effect in a subject |
| 07/11/2002 | WO2001087262A3 Stabilized steroidal suspension |
| 07/11/2002 | WO2001082918A8 Method for the prevention of apoptosis |
| 07/11/2002 | WO2001080896A3 Flavopiridol drug combinations and methods with reduced side effects |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001076593A3 Bile secretion promoting composition a 15-keto prostaglandin |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | WO2001074389A3 Improved treatment of neovascularization |
| 07/11/2002 | WO2001068145A3 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 07/11/2002 | WO2001068067A3 Use of deramciclane for the treatment of anxiety and depression |
| 07/11/2002 | WO2001056551A3 Method and formulation for treatment of vasoconstriction |
| 07/11/2002 | WO2001049300A3 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 07/11/2002 | WO2001049242A3 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001041715A3 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 07/11/2002 | WO2001040187A3 Compound having effect of promoting neuron differentiation |
| 07/11/2002 | WO2001039763A3 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 07/11/2002 | WO2001035939A3 Oleamide in epilepsy |
| 07/11/2002 | WO2001034225A3 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 07/11/2002 | WO2001034125A3 Therapeutic use and formulation of (-)-tramadol |
| 07/11/2002 | WO2001032159A3 Methods and formulations for the treatment of infectious bursal disease in avian subjects |
| 07/11/2002 | WO2001029054A3 Medicaments for treatment of respiratory syncytial virus infections |
| 07/11/2002 | WO2001028540A3 Agent for treating cephalic pain |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001024785A3 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 07/11/2002 | WO2001021190A9 Treatment for narcolepsy |
| 07/11/2002 | WO2001021178A3 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs |
| 07/11/2002 | WO2001020969A3 Use of ribose to prevent cramping and soreness in muscles |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2001017563A3 Integrin-mediated drug targeting |
| 07/11/2002 | WO2001017517A3 Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001016120A9 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 07/11/2002 | WO2001013927A9 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001010430A9 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 07/11/2002 | WO2001008669A3 Therapeutic agents for lymphoedema |
| 07/11/2002 | WO2001003685A3 Novel prodrugs for antimicrobial amidines |
| 07/11/2002 | WO2001003680A3 Compounds for inhibiting diseases and preparing cells for transplantation |
| 07/11/2002 | WO2001000138A3 Use of hydroxydiphenyl ether class of chemicals, as exemplified by triclosan, as an antimalarial and identification of fatty acid synthesis as its target |
| 07/11/2002 | WO2000075144A9 Peroxynitrite decomposition catalysts and methods of use thereof |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | WO2000072834A3 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 07/11/2002 | WO2000067024A9 Cancer treatment with endothelin receptor antagonists |
| 07/11/2002 | WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 07/11/2002 | WO2000064911A9 Ligands for metabotropic glutamate receptors |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000062067A9 Novel transduction molecules and methods for using same |
| 07/11/2002 | WO2000061231A3 Medical use |
| 07/11/2002 | WO2000049937A9 Trpm-2 antisense therapy |
| 07/11/2002 | WO2000028982A3 Increasing bone strength with selected bisphosphonates |
| 07/11/2002 | US20020091446 Interspinous process distraction system and method with positionable wing and method |
| 07/11/2002 | US20020091424 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and benzalkonium chloride |